David Schellenberg is Professor of Malaria and International Health at the London School of Hygiene & Tropical Medicine. He is Deputy Director of the Malaria Capacity Development Consortium. David directs the ACT consortium, which is answering key questions on malaria drug delivery by optimising the use of rapid diagnostic tests to improve targeting of treatment, and facilitating access to effective anti-malarial drugs, particularly the artemesinin-based Combination Therapies (ACTs). The Consortium includes pharmacovigilance and drug quality monitoring components amongst its 14 projects in 10 countries. David has an interest in malaria vaccine development and works on behalf of the Malaria Vaccine Initiative to support the RTS,S clinical development program.